These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 37955908

  • 1. Torsemide vs Furosemide Among Patients With New-Onset vs Worsening Chronic Heart Failure: A Substudy of the TRANSFORM-HF Randomized Clinical Trial.
    Krim SR, Anand S, Greene SJ, Chen A, Wojdyla D, Vilaro J, Haught H, Herre JM, Eisenstein EL, Anstrom KJ, Pitt B, Velazquez EJ, Mentz RJ.
    JAMA Cardiol; 2024 Feb 01; 9(2):182-188. PubMed ID: 37955908
    [Abstract] [Full Text] [Related]

  • 2. Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
    Greene SJ, Velazquez EJ, Anstrom KJ, Clare RM, DeWald TA, Psotka MA, Ambrosy AP, Stevens GR, Rommel JJ, Alexy T, Ketema F, Kim DY, Desvigne-Nickens P, Pitt B, Eisenstein EL, Mentz RJ, TRANSFORM-HF Investigators.
    Circulation; 2023 Jul 11; 148(2):124-134. PubMed ID: 37212600
    [Abstract] [Full Text] [Related]

  • 3. On-treatment analysis of torsemide versus furosemide for patients hospitalized for heart failure: A post-hoc analysis of TRANSFORM-HF.
    Kittipibul V, Mentz RJ, Clare RM, Wojdyla DM, Anstrom KJ, Eisenstein EL, Ambrosy AP, Goyal P, Skopicki HA, Ketema F, Kim DY, Desvigne-Nickens P, Pitt B, Velazquez EJ, Greene SJ.
    Eur J Heart Fail; 2024 Jul 11; 26(7):1518-1523. PubMed ID: 38745502
    [Abstract] [Full Text] [Related]

  • 4. Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
    Mentz RJ, Anstrom KJ, Eisenstein EL, Sapp S, Greene SJ, Morgan S, Testani JM, Harrington AH, Sachdev V, Ketema F, Kim DY, Desvigne-Nickens P, Pitt B, Velazquez EJ, TRANSFORM-HF Investigators.
    JAMA; 2023 Jan 17; 329(3):214-223. PubMed ID: 36648467
    [Abstract] [Full Text] [Related]

  • 5. Impact of baseline kidney dysfunction on oral diuretic efficacy following hospitalization for heart failure - insights from TRANSFORM-HF.
    Martens P, Greene SJ, Mentz RJ, Li S, Wojdyla D, Kapelios CJ, Mullens W, Hall ME, Ketema F, Kim DY, Eisenstein EL, Anstrom K, Fang JC, Pitt B, Velazquez EJ, Tang WHW.
    Eur J Heart Fail; 2024 May 17; 26(5):1242-1250. PubMed ID: 38558520
    [Abstract] [Full Text] [Related]

  • 6. Torsemide Versus Furosemide After Discharge in Patients Hospitalized With Heart Failure Across the Spectrum of Ejection Fraction: Findings From TRANSFORM-HF.
    Kapelios CJ, Greene SJ, Mentz RJ, Ikeaba U, Wojdyla D, Anstrom KJ, Eisenstein EL, Pitt B, Velazquez EJ, Fang JC, TRANSFORM-HF Investigators.
    Circ Heart Fail; 2024 Mar 17; 17(3):e011246. PubMed ID: 38436075
    [Abstract] [Full Text] [Related]

  • 7. Effect of Furosemide Versus Torsemide on Hospitalizations and Mortality in Patients With Heart Failure: A Meta-Analysis of Randomized Controlled Trials.
    Singh S, Goel S, Duhan S, Chaudhary R, Garg A, Tantry US, Gurbel PA.
    Am J Cardiol; 2023 Nov 01; 206():42-48. PubMed ID: 37677884
    [Abstract] [Full Text] [Related]

  • 8. Diuretic dosing and outcomes with torsemide and furosemide following hospitalization for heart failure: The TRANSFORM-HF trial.
    Nouhravesh N, Greene SJ, Clare R, Wojdyla D, Anstrom KJ, Velazquez E, Pitt B, Mentz RJ, Psotka MA.
    Eur J Heart Fail; 2024 Oct 04. PubMed ID: 39363809
    [Abstract] [Full Text] [Related]

  • 9. Comparative Effect of Loop Diuretic Prescription on Mortality and Heart Failure Readmission.
    Virkud AV, Chang PP, Funk MJ, Kshirsagar AV, Edwards JK, Pate V, Kosorok MR, Gower EW.
    Am J Cardiol; 2024 Jan 01; 210():208-216. PubMed ID: 37972425
    [Abstract] [Full Text] [Related]

  • 10. Clinical Outcomes With Furosemide Versus Torsemide in Patients With Heart Failure: An Updated Systematic Review and Meta-Analysis.
    Siddiqi AK, Javaid H, Ahmed M, Dhawadi S, Batool L, Zahid M, Muslim MO, Naeem K, Mahmood F, Hussain A.
    Curr Probl Cardiol; 2023 Nov 01; 48(11):101927. PubMed ID: 37453532
    [Abstract] [Full Text] [Related]

  • 11. A comprehensive review of the loop diuretics: should furosemide be first line?
    Wargo KA, Banta WM.
    Ann Pharmacother; 2009 Nov 01; 43(11):1836-47. PubMed ID: 19843838
    [Abstract] [Full Text] [Related]

  • 12. An evaluation of torsemide in patients with heart failure and renal disease.
    Peters AE, Mentz RJ, DeWald TA, Greene SJ.
    Expert Rev Cardiovasc Ther; 2022 Jan 01; 20(1):5-11. PubMed ID: 34936522
    [Abstract] [Full Text] [Related]

  • 13. The Importance of Worsening Heart Failure in Ambulatory Patients: Definition, Characteristics, and Effects of Amino-Terminal Pro-B-Type Natriuretic Peptide Guided Therapy.
    Mallick A, Gandhi PU, Gaggin HK, Ibrahim N, Januzzi JL.
    JACC Heart Fail; 2016 Sep 01; 4(9):749-55. PubMed ID: 27179830
    [Abstract] [Full Text] [Related]

  • 14. Use of short-acting vs. long-acting loop diuretics after heart failure hospitalization.
    Imaeda S, Shiraishi Y, Kohsaka S, Niimi N, Goda A, Nagatomo Y, Takei M, Saji M, Nakano S, Kohno T, Fukuda K, Yoshikawa T.
    ESC Heart Fail; 2022 Oct 01; 9(5):2967-2977. PubMed ID: 35730147
    [Abstract] [Full Text] [Related]

  • 15. Pragmatic Design of Randomized Clinical Trials for Heart Failure: Rationale and Design of the TRANSFORM-HF Trial.
    Greene SJ, Velazquez EJ, Anstrom KJ, Eisenstein EL, Sapp S, Morgan S, Harding T, Sachdev V, Ketema F, Kim DY, Desvigne-Nickens P, Pitt B, Mentz RJ, TRANSFORM-HF Investigators.
    JACC Heart Fail; 2021 May 01; 9(5):325-335. PubMed ID: 33714745
    [Abstract] [Full Text] [Related]

  • 16. Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis.
    Miles JA, Hanumanthu BK, Patel K, Chen M, Siegel RM, Kokkinidis DG.
    J Cardiovasc Med (Hagerstown); 2019 Jun 01; 20(6):379-388. PubMed ID: 30950982
    [Abstract] [Full Text] [Related]

  • 17. Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).
    Mentz RJ, Hasselblad V, DeVore AD, Metra M, Voors AA, Armstrong PW, Ezekowitz JA, Tang WH, Schulte PJ, Anstrom KJ, Hernandez AF, Velazquez EJ, O'Connor CM.
    Am J Cardiol; 2016 Feb 01; 117(3):404-11. PubMed ID: 26704029
    [Abstract] [Full Text] [Related]

  • 18. Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology.
    Ozierański K, Balsam P, Kapłon-Cieślicka A, Tymińska A, Kowalik R, Grabowski M, Peller M, Wancerz A, Marchel M, Crespo-Leiro MG, Maggioni AP, Drożdż J, Filipiak KJ, Opolski G.
    Cardiovasc Drugs Ther; 2019 Feb 01; 33(1):77-86. PubMed ID: 30649675
    [Abstract] [Full Text] [Related]

  • 19. Comparing torsemide versus furosemide in patients with heart failure: A meta-analysis.
    Kido K, Shimizu M, Hashiguchi M.
    J Am Pharm Assoc (2003); 2019 Feb 01; 59(3):432-438. PubMed ID: 30846351
    [Abstract] [Full Text] [Related]

  • 20. Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study.
    Rahhal A, Saad MO, Tawengi K, Assi AAR, Habra M, Ahmed D.
    BMC Cardiovasc Disord; 2019 May 28; 19(1):127. PubMed ID: 31138146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.